Pay in 4 interest-free payments of $5.60 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
An R2R3 MYB transcription factor confers brown planthopper resistance by regulating the phenylalanine ammonia-lyase pathway in rice
The Big Trial of a GLP-1 drug (Wegovy) to Reduce Major Cardiovascular Events Presented at the American Heart Association and simultaneously published in NEJM today is the trial of over 17,600 patients who were randomly assigned either the GLP-1 semaglutide (a glucagon-like peptide-1 receptor agonist) or placebo and were followed for well over 3 years
This boundary keeps the article aligned with laboratory research-use-only positioning
We matched the comparison groups using a multivariable logistic regression to estimate the propensity score and performed nearest number matching with a caliper of 0.01 with no replacement, using same technique as our primary analysis
1 GLP-1 drugs have become increasingly popular in recent years
